Dr. Kolodney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Morgantown, WV 26506Phone+1 304-598-4800Fax+1 304-598-6382
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2004 - 2007
Legacy Health/Emanuel Medical CenterResidency, Internal Medicine, 2001 - 2004
NYU Grossman School of MedicineResidency, Pediatrics, 2000 - 2001
University of Texas M D Anderson Cancer CenterInternship, Transitional Year, 1999 - 2000
University of Arizona College of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2003 - Present
OR State Medical License 2003 - Present
WV State Medical License 2016 - 2026
FL State Medical License 2016 - 2018
VA State Medical License 2012 - 2016
WA State Medical License 2011 - 2012
AZ State Medical License 2003 - 2009- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells Start of enrollment: 2019 Jul 19
- Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells Start of enrollment: 2020 Sep 01
Publications & Presentations
PubMed
- 16 citationsNew mechanistic explanation for the localization of ulcers in the rat duodenum: Role of iron and selective uptake of cysteamineTetyana Khomenko, Joanna Kolodney, John T. Pinto, Gordon D. McLaren, Xiaoming Deng
Archives of Biochemistry and Biophysics. 2012-09-01 - 2 citationsFactors associated with immune checkpoint inhibitor use among older adults with late-stage melanoma: A population-based studyPragya Rai, Chan Shen, Joanna Kolodney, Kimberly M. Kelly, V Scott
Medicine. 2021-02-19 - 1 citationsProgrammed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study.Katelyn Sarkovics, Joanna A Kolodney, Michael S Kolodney
The British Journal of Dermatology. 2024-07-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
